Showing results (711-720 of 1,008) with videos related to
Sort By:
Pageof 101
Cardiovascular Therapeutics|February 14, 2015
Coronary artery ectasia in atherosclerotic coronary artery disease, inflammatory disorders, and sickle cell diseaseAli DahhanCardiovascular Therapeutics|August 3, 2018
TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in miceZeena Eblimit, Sundararajah Thevananther, Saul J Karpen, et al.Cardiovascular Therapeutics|October 4, 2018
Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency departmentMichal M Farkowski, Aleksander Maciag, Malgorzata Zurawska, et al.Cardiovascular Therapeutics|May 18, 2018
The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fractionPieter Martens, Hanne Beliën, Matthias Dupont, et al.Cardiovascular Therapeutics|March 20, 2015
Renal denervation--hypes and hopesJoanna Lewek, Krzysztof Kaczmarek, Evgeniy Pokushalov, et al.Cardiovascular Therapeutics|February 23, 2023
DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1α Pathway and ERp57Xiaojing Zhang, Ximin Wu, Huihui Hu, et al.Cardiovascular Therapeutics|March 3, 2025
The Acute Effects of Motor Imagery Combined With Action Observation Breathing Exercise on Cardiorespiratory Responses, Brain Activity, and Cognition: A Randomized, Controlled TrialEbrar Atak, Amine AtaçCardiovascular Therapeutics|January 21, 2025
Imperatorin's Effect on Myocardial Infarction Based on Network Pharmacology and Molecular DockingRuizhe Zhang, Peng Wang, Yao Jin, et al.Cardiovascular Therapeutics|January 19, 2026
From the Liver to Heart in Nonalcoholic Fatty Liver Disease: Single-Cell and Serum Evidence for Cytokeratin 18 in Predicting Cardiovascular RiskHongjing Xu, Xiang Ma, Fengjuan Chen, et al.Cardiovascular Therapeutics|November 20, 2025
Risk Factors and Regression of Coronary Aneurysms in Infants With Kawasaki DiseaseYunxia Liu, Yumao Zhang, Ying Xie, et al.Pageof 101